Balyasny Asset Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,285
| Closed | -$235K | – | 2499 |
|
|
2025
Q1 | $235K | Sell |
21,285
-3,196
| -13% | -$35.3K | ﹤0.01% | 1773 |
|
|
2024
Q4 | $261K | Sell |
24,481
-4,131
| -14% | -$44K | ﹤0.01% | 1678 |
|
|
2024
Q3 | $363K | Sell |
28,612
-145,354
| -84% | -$1.85M | ﹤0.01% | 1661 |
|
|
2024
Q2 | $2.92M | Buy |
173,966
+148,995
| +597% | +$2.5M | 0.01% | 966 |
|
|
2024
Q1 | $375K | Buy |
+24,971
| New | +$375K | ﹤0.01% | 1579 |
|
|
2022
Q4 | – | Sell |
-11,868
| Closed | -$99K | – | 2769 |
|
|
2022
Q3 | $99K | Buy |
+11,868
| New | +$99K | ﹤0.01% | 1923 |
|